Jazz Pharmaceuticals Stock Guidance | NASDAQ:JAZZ

Comments

Jazz Pharmaceuticals PLC Stock Guidance

JAZZNASDAQ

Trade with Public

$183.86

1.841.01%

Last update: Mar 17, 3:18 PM

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Government Trades Stock Report

Jazz Pharmaceuticals (JAZZ) last issued guidance on February 24, 2026 for fiscal year 2026. The company guided revenue in the range of $4.25B - $4.50B for the period.

Compared to prior guidance, Jazz Pharmaceuticals raised its revenue forecast from a prior range of $4.17B - $4.28B.

Jazz Pharmaceuticals has issued 20 guidance updates between May 4, 2022 and February 24, 2026. During this period, the company raised its outlook 10 times and lowered it 4 times, providing investors with insight into management's evolving expectations.

Latest Guidance Date

Feb 24, 2026

Guidance Period

Full Year 2026

Revenue Guidance Range

$4.25B - $4.50B

Jazz Pharmaceuticals Guidance History

Review all historical guidance issued by Jazz Pharmaceuticals, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for Jazz Pharmaceuticals (JAZZ)?

The most recent guidance for Jazz Pharmaceuticals (JAZZ) was reported on February 24, 2026 for the fiscal year 2026. Jazz Pharmaceuticals forecasted revenue between $4.25B and $4.50B for the period.

What EPS range did Jazz Pharmaceuticals (JAZZ) guide for?

Jazz Pharmaceuticals (JAZZ) guided EPS in the range of $7.65 to $8.45 for the fiscal year 2025. The consensus analyst EPS estimate is $3.83.

What revenue range did Jazz Pharmaceuticals (JAZZ) guide for?

Jazz Pharmaceuticals (JAZZ) guided revenue in the range of $4.25B to $4.50B for the fiscal year 2026.

Did Jazz Pharmaceuticals (JAZZ) raise or lower guidance?

Jazz Pharmaceuticals (JAZZ) raised its revenue guidance from a prior range of $4.17B - $4.28B to $4.25B - $4.50B for the fiscal year 2026.

When did Jazz Pharmaceuticals (JAZZ) last issue guidance?

Jazz Pharmaceuticals (JAZZ) last issued guidance on February 24, 2026 for the fiscal year 2026.

People Also Watch

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

NASDAQ:AXSM

$160.65

1.53%

Jazz Pharmaceuticals (JAZZ) last issued guidance on February 24, 2026 for fiscal year 2026. The company guided revenue in the range of $4.25B - $4.50B for the period.

Compared to prior guidance, Jazz Pharmaceuticals raised its revenue forecast from a prior range of $4.17B - $4.28B.

Latest Guidance Date

Feb 24, 2026

Guidance Period

Full Year 2026

Revenue Guidance Range

$4.25B - $4.50B

Jazz Pharmaceuticals Guidance History

Review all historical guidance issued by Jazz Pharmaceuticals, including EPS and revenue forecasts across quarterly and annual periods.

											Get Alert
02/24/2026	JAZZ	Jazz Pharmaceuticals	FY	2026	—	—	—	$4.25B	$4.50B	$4.40B	Get Alert
11/05/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$7.65	$8.45	$3.83	$4.17B	$4.28B	$4.22B	Get Alert
08/05/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$4.80	$5.60	$3.76	$4.15B	$4.30B	$4.24B	Get Alert
05/06/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$20.50	$22.10	$23.23	$4.15B	$4.40B	$4.29B	Get Alert
02/25/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$22.50	$24.00	$24.00	$4.15B	$4.40B	$4.34B	Get Alert
01/13/2025	JAZZ	Jazz Pharmaceuticals	FY	2024	—	—	—	$4.00B	$4.10B	$4.04B	Get Alert
12/16/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	—	—	—	$4.00B	$4.10B	$4.04B	Get Alert
11/06/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$19.50	$20.60	$19.59	$4.00B	$4.10B	$4.04B	Get Alert
07/31/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$19.20	$20.30	$18.51	$4.00B	$4.10B	$4.05B	Get Alert
05/01/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$18.15	$19.35	$18.93	$4.00B	$4.20B	$4.10B	Get Alert
02/28/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$18.15	$19.35	$19.94	$4.00B	$4.20B	$4.09B	Get Alert
01/08/2024	JAZZ	Jazz Pharmaceuticals	FY	2023	—	—	—	$3.81B	$3.81B	$3.83B	Get Alert
01/08/2024	JAZZ	Jazz Pharmaceuticals	FY	2025	—	—	—	$5.00B	$5.00B	—	Get Alert
11/08/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$18.15	$19.00	$18.66	$3.75B	$3.88B	$3.83B	Get Alert
08/09/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$18.15	$19.00	$17.48	$3.73B	$3.88B	$3.78B	Get Alert
05/10/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$16.90	$17.85	$17.44	$3.67B	$3.88B	$3.78B	Get Alert
03/01/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$16.90	$17.85	$18.00	$3.67B	$3.88B	$3.76B	Get Alert
11/09/2022	JAZZ	Jazz Pharmaceuticals	FY	2022	$17.20	$17.85	$17.41	$3.60B	$3.70B	$3.65B	Get Alert
08/03/2022	JAZZ	Jazz Pharmaceuticals	FY	2022	$16.70	$17.70	$17.09	$3.50B	$3.70B	$3.60B	Get Alert
05/04/2022	JAZZ	Jazz Pharmaceuticals	FY	2022	—	—	—	$3.50B	$3.70B	$3.58B	Get Alert

Loading calendar...

FAQ

What is the most recent guidance for Jazz Pharmaceuticals (JAZZ)?

The most recent guidance for Jazz Pharmaceuticals (JAZZ) was reported on February 24, 2026 for the fiscal year 2026. Jazz Pharmaceuticals forecasted revenue between $4.25B and $4.50B for the period.

What EPS range did Jazz Pharmaceuticals (JAZZ) guide for?

Jazz Pharmaceuticals (JAZZ) guided EPS in the range of $7.65 to $8.45 for the fiscal year 2025. The consensus analyst EPS estimate is $3.83.

What revenue range did Jazz Pharmaceuticals (JAZZ) guide for?

Jazz Pharmaceuticals (JAZZ) guided revenue in the range of $4.25B to $4.50B for the fiscal year 2026.

Did Jazz Pharmaceuticals (JAZZ) raise or lower guidance?

Jazz Pharmaceuticals (JAZZ) raised its revenue guidance from a prior range of $4.17B - $4.28B to $4.25B - $4.50B for the fiscal year 2026.

When did Jazz Pharmaceuticals (JAZZ) last issue guidance?

Jazz Pharmaceuticals (JAZZ) last issued guidance on February 24, 2026 for the fiscal year 2026.

People Also Watch

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

NASDAQ:AXSM

$160.65

1.53%

											Get Alert
02/24/2026	JAZZ	Jazz Pharmaceuticals	FY	2026	—	—	—	$4.25B	$4.50B	$4.40B	Get Alert
11/05/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$7.65	$8.45	$3.83	$4.17B	$4.28B	$4.22B	Get Alert
08/05/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$4.80	$5.60	$3.76	$4.15B	$4.30B	$4.24B	Get Alert
05/06/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$20.50	$22.10	$23.23	$4.15B	$4.40B	$4.29B	Get Alert
02/25/2025	JAZZ	Jazz Pharmaceuticals	FY	2025	$22.50	$24.00	$24.00	$4.15B	$4.40B	$4.34B	Get Alert
01/13/2025	JAZZ	Jazz Pharmaceuticals	FY	2024	—	—	—	$4.00B	$4.10B	$4.04B	Get Alert
12/16/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	—	—	—	$4.00B	$4.10B	$4.04B	Get Alert
11/06/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$19.50	$20.60	$19.59	$4.00B	$4.10B	$4.04B	Get Alert
07/31/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$19.20	$20.30	$18.51	$4.00B	$4.10B	$4.05B	Get Alert
05/01/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$18.15	$19.35	$18.93	$4.00B	$4.20B	$4.10B	Get Alert
02/28/2024	JAZZ	Jazz Pharmaceuticals	FY	2024	$18.15	$19.35	$19.94	$4.00B	$4.20B	$4.09B	Get Alert
01/08/2024	JAZZ	Jazz Pharmaceuticals	FY	2023	—	—	—	$3.81B	$3.81B	$3.83B	Get Alert
01/08/2024	JAZZ	Jazz Pharmaceuticals	FY	2025	—	—	—	$5.00B	$5.00B	—	Get Alert
11/08/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$18.15	$19.00	$18.66	$3.75B	$3.88B	$3.83B	Get Alert
08/09/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$18.15	$19.00	$17.48	$3.73B	$3.88B	$3.78B	Get Alert
05/10/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$16.90	$17.85	$17.44	$3.67B	$3.88B	$3.78B	Get Alert
03/01/2023	JAZZ	Jazz Pharmaceuticals	FY	2023	$16.90	$17.85	$18.00	$3.67B	$3.88B	$3.76B	Get Alert
11/09/2022	JAZZ	Jazz Pharmaceuticals	FY	2022	$17.20	$17.85	$17.41	$3.60B	$3.70B	$3.65B	Get Alert
08/03/2022	JAZZ	Jazz Pharmaceuticals	FY	2022	$16.70	$17.70	$17.09	$3.50B	$3.70B	$3.60B	Get Alert
05/04/2022	JAZZ	Jazz Pharmaceuticals	FY	2022	—	—	—	$3.50B	$3.70B	$3.58B	Get Alert

Benzinga

Benzinga

Jazz Pharmaceuticals PLC Stock Guidance

Jazz Pharmaceuticals Guidance History

FAQ

What is the most recent guidance for Jazz Pharmaceuticals (JAZZ)?

What EPS range did Jazz Pharmaceuticals (JAZZ) guide for?

What revenue range did Jazz Pharmaceuticals (JAZZ) guide for?

Did Jazz Pharmaceuticals (JAZZ) raise or lower guidance?

When did Jazz Pharmaceuticals (JAZZ) last issue guidance?

People Also Watch

Jazz Pharmaceuticals Guidance History

FAQ

What is the most recent guidance for Jazz Pharmaceuticals (JAZZ)?

What EPS range did Jazz Pharmaceuticals (JAZZ) guide for?

What revenue range did Jazz Pharmaceuticals (JAZZ) guide for?

Did Jazz Pharmaceuticals (JAZZ) raise or lower guidance?

When did Jazz Pharmaceuticals (JAZZ) last issue guidance?

People Also Watch